Učitavanje...
Host genetic factors in predicting response status in chronic hepatitis B patients discontinuing nucleos(t)ide analogs
BACKGROUND/AIMS: The optimal duration of nucleos(t)ide analogs (NAs) therapy in chronic hepatitis B (CHB) patients remains unsatisfactory. Previous studies have confirmed the important role of host genetic factors in determining the outcome of HBV infection. This study tries to determine the role of...
Spremljeno u:
| Izdano u: | Saudi J Gastroenterol |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Medknow Publications & Media Pvt Ltd
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5848322/ https://ncbi.nlm.nih.gov/pubmed/29451182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/sjg.SJG_228_17 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|